文献速递胸部肿瘤消化系统肿瘤乳腺癌

2025年癌症治疗与生存统计

Cancer treatment and survivorship statistics, 2025.
PubMed 文献 · CA Cancer J Clin · 2025-05-30

美国癌症协会与国家癌症研究所协作,基于SEER登记处、CDC国家卫生统计中心和美国人口普查局数据估算美国癌症患病情况,并利用国家癌症数据库呈现治疗模式。男性最常见为前列腺癌(3,552,460例)、皮肤黑色素瘤(816,580例)和结直肠癌(729,550例),女性为乳腺癌(4,305,570例)、子宫体癌(945,540例)和甲状腺癌(859,890例)。约51%幸存者在过去10年内确诊,79%年龄在60岁及以上;2021年治疗存在种族差异,例如I-II期肺癌黑人接受手术比例低于白人(47% vs 52%),I期直肠癌黑人接受直肠切除术或直肠结肠切除术比例为39% vs 白人64%。

要点

  • 男性最常见为前列腺癌(3,552,460例)、皮肤黑色素瘤(816,580例)和结直肠癌(729,550例)。
  • 女性最常见为乳腺癌(4,305,570例)、子宫体癌(945,540例)和甲状腺癌(859,890例)。

核心结论

  • 美国癌症幸存者数量持续上升,需扩大高质量诊疗和生存资源的可及性以减少差异。

研究设计与样本

  • 美国癌症协会与国家癌症研究所每三年协作,基于SEER登记处、CDC国家卫生统计中心和美国人口普查局数据估算癌症患病情况,并从国家癌症数据库呈现治疗模式。

主要发现

  • 男性最常见为前列腺癌(3,552,460例)、皮肤黑色素瘤(816,580例)和结直肠癌(729,550例)。
  • 女性最常见为乳腺癌(4,305,570例)、子宫体癌(945,540例)和甲状腺癌(859,890例)。
  • 约51%幸存者在过去10年内确诊,79%年龄在60岁及以上。
  • 2021年I-II期肺癌黑人接受手术比例低于白人(47% vs 52%);I期直肠癌黑人接受直肠切除术或直肠结肠切除术比例为39% vs 白人64%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The number of people living with a history of cancer in the United States continues to rise because of the growth and aging of the population as well as improved survival through advances in early detection and treatment. To assist the public health community serve the needs of these survivors, the American Cancer Society and the National Cancer Institute collaborate triennially to estimate cancer prevalence in the United States using data from the Surveillance, Epidemiology, and End Results cancer registries, the Centers for Disease Control and Prevention's National Center for Health Statistics, and the United States Census Bureau. In addition, cancer treatment patterns are presented from the National Cancer Database along with a brief overview of treatment-related side effects. As of January 1, 2025, about 18.6 million people were living in the United States with a history of cancer, and this number is projected to exceed 22 million by 2035. The three most prevalent cancers are prostate (3,552,460), melanoma of the skin (816,580), and colorectum (729,550) among males and breast (4,305,570), uterine corpus (945,540), and thyroid (859,890) among females. About one half (51%) of survivors were diagnosed within the past 10 years, and nearly four fifths (79%) were aged 60 years and older. Racial differences in treatment in 2021 were common across disease stage; for example, Black people with stage I-II lung cancer were less likely to undergo surgery than their White counterparts (47% vs. 52%). Larger disparities exist for rectal cancer, for which 39% of Black people with stage I disease undergo proctectomy or proctocolectomy compared to 64% of their White counterparts. Targeted, multi-level efforts to expand access to high-quality care and survivorship resources are vital to reducing disparities and advancing support for all survivors of cancer.

来源:CA Cancer J Clin,查看原文。版权归原作者所有。

引用

  1. Wagle NS, Nogueira L, Devasia TP, et al. Cancer treatment and survivorship statistics, 2025. CA Cancer J Clin. 2025. PMID: 40445120. doi:10.3322/caac.70011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。